Rx Rundown: Novartis, Sage Therapeutics, Eli Lilly and more
Deals: Halozyme made a €2 billion buyout offer for drug developer Evotec. Novartis lifted its midterm sales guidance and purchased neuro startup Kate Therapeutics for up to $1.1 billion. Days earlier, Novartis struck a license and collaboration deal with …